Product Packaging and Labeling

Drug Names, Labels, and Packaging

Policy 9908

11/01/1999 Introduced
03/01/2004 Reapproved
12/01/2008 Reapproved
10/01/2012 Reapproved

AMCP encourages drug manufacturers and the FDA to work with pharmacists, physicians, other health care professionals and professional organizations to design and adopt drug names, labeling, and packaging that will avoid confusion and help prevent medication errors. 

Regulation of Dietary Supplements

Policy 0110

03/01/2001 Introduced
02/01/2006 Revised
12/01/2010 Reapproved

AMCP advocates the modification of the Dietary Supplement Health and Education Act or enactment of other legislation for all products falling under the Act, requiring that dietary supplement manufacturers provide evidence of product efficacy and safety, label products with full disclosure of all components (including source, strength, and recommendations for use), and implement a mechanism to remove promptly unsafe or ineffective products from the marketplace. AMCP encourages expansion of the National Institutes of Health Office of Dietary Supplement's Internet site to include reports of adverse health events from manufacturers, health care professionals, consumers, the Food and Drug Administration, and the Center for Food Safety and Applied Nutrition.